Get started
Avid Bioservices, Inc.Avid Bioservices, Inc.Avid Bioservices, Inc.

Avid Bioservices, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

CDMO chart


Full chart

CDMO upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪782.91 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.39 USD
Net income (FY)
‪−140.75 M‬ USD
Revenue (FY)
‪139.91 M‬ USD
Shares float
‪63.30 M‬
Beta (1Y)
2.24

Employees


Employees (FY)
371
Change (1Y)
+6 +1.64%
Revenue / Employee (1Y)
‪377.12 K‬ USD
Net income / Employee (1Y)
‪−379.39 K‬ USD

About Avid Bioservices, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Nicholas S. Green
Website
avidbio.com
Headquarters
Tustin
Founded
1981
FIGI
BBG000JDWKY3
Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CDMO news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CDMO is 12.33 USD — it has increased by 0.69% in the past 24 hours. Watch Avid Bioservices, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Avid Bioservices, Inc. stocks are traded under the ticker CDMO.
CDMO stock has risen by 0.28% compared to the previous week, the month change is a −0.28% fall, over the last year Avid Bioservices, Inc. has showed a 81.25% increase.
We've gathered analysts' opinions on Avid Bioservices, Inc. future price: according to them, CDMO price has a max estimate of 12.50 USD and a min estimate of 12.50 USD. Watch CDMO chart and read a more detailed Avid Bioservices, Inc. stock forecast: see what analysts think of Avid Bioservices, Inc. and suggest that you do with its stocks.
CDMO reached its all-time high on Mar 7, 2000 with the price of 581.70 USD, and its all-time low was 1.97 USD and was reached on Jan 12, 2017. View more price dynamics on CDMO chart.
See other stocks reaching their highest and lowest prices.
CDMO stock is 0.73% volatile and has beta coefficient of 2.24. Track Avid Bioservices, Inc. stock price on the chart and check out the list of the most volatile stocks — is Avid Bioservices, Inc. there?
Today Avid Bioservices, Inc. has the market capitalization of ‪782.91 M‬, it has decreased by −0.33% over the last week.
Yes, you can track Avid Bioservices, Inc. financials in yearly and quarterly reports right on TradingView.
Avid Bioservices, Inc. is going to release the next earnings report on Mar 17, 2025. Keep track of upcoming events with our Earnings Calendar.
CDMO earnings for the last quarter are −0.27 USD per share, whereas the estimation was −0.12 USD resulting in a −129.79% surprise. The estimated earnings for the next quarter are −0.06 USD per share. See more details about Avid Bioservices, Inc. earnings.
Avid Bioservices, Inc. revenue for the last quarter amounts to ‪33.50 M‬ USD, despite the estimated figure of ‪33.80 M‬ USD. In the next quarter, revenue is expected to reach ‪41.90 M‬ USD.
CDMO net income for the last quarter is ‪−17.41 M‬ USD, while the quarter before that showed ‪−5.53 M‬ USD of net income which accounts for −214.53% change. Track more Avid Bioservices, Inc. financial stats to get the full picture.
No, CDMO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 371.00 employees. See our rating of the largest employees — is Avid Bioservices, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Avid Bioservices, Inc. EBITDA is ‪−7.54 M‬ USD, and current EBITDA margin is −5.41%. See more stats in Avid Bioservices, Inc. financial statements.
Like other stocks, CDMO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Avid Bioservices, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Avid Bioservices, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Avid Bioservices, Inc. stock shows the buy signal. See more of Avid Bioservices, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.